These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


773 related items for PubMed ID: 16824616

  • 1. Validating the bipolar spectrum in the French National EPIDEP Study: overview of the phenomenology and relative prevalence of its clinical prototypes.
    Akiskal HS, Akiskal KK, Lancrenon S, Hantouche EG, Fraud JP, Gury C, Allilaire JF.
    J Affect Disord; 2006 Dec; 96(3):197-205. PubMed ID: 16824616
    [Abstract] [Full Text] [Related]

  • 2. Validating the soft bipolar spectrum in the French National EPIDEP Study: the prominence of BP-II 1/2.
    Akiskal HS, Akiskal KK, Lancrenon S, Hantouche E.
    J Affect Disord; 2006 Dec; 96(3):207-13. PubMed ID: 16647762
    [Abstract] [Full Text] [Related]

  • 3. [Frequency and clinical aspects of bipolar II disorder in a French multicenter study: EPIDEP].
    Allilaire JF, Hantouche EG, Sechter D, Bourgeois ML, Azorin JM, Lancrenon S, Châtenet-Duchêne L, Akiskal HS.
    Encephale; 2001 Dec; 27(2):149-58. PubMed ID: 11407267
    [Abstract] [Full Text] [Related]

  • 4. The DSM-IV and ICD-10 categories of recurrent [major] depressive and bipolar II disorders: evidence that they lie on a dimensional spectrum.
    Akiskal HS, Benazzi F.
    J Affect Disord; 2006 May; 92(1):45-54. PubMed ID: 16488021
    [Abstract] [Full Text] [Related]

  • 5. Validating affective temperaments in their subaffective and socially positive attributes: psychometric, clinical and familial data from a French national study.
    Akiskal HS, Akiskal K, Allilaire JF, Azorin JM, Bourgeois ML, Sechter D, Fraud JP, Chatenêt-Duchêne L, Lancrenon S, Perugi G, Hantouche EG.
    J Affect Disord; 2005 Mar; 85(1-2):29-36. PubMed ID: 15780673
    [Abstract] [Full Text] [Related]

  • 6. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG, Akiskal HS, Lancrenon S, Chatenêt-Duchêne L.
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [Abstract] [Full Text] [Related]

  • 7. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS, Benazzi F, Perugi G, Rihmer Z.
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [Abstract] [Full Text] [Related]

  • 8. Irritable-hostile depression: further validation as a bipolar depressive mixed state.
    Benazzi F, Akiskal H.
    J Affect Disord; 2005 Feb; 84(2-3):197-207. PubMed ID: 15708417
    [Abstract] [Full Text] [Related]

  • 9. Biphasic course in bipolar II outpatients: prevalence and clinical correlates of a cyclic pattern described by Baillarger and Falret in hospitalised patients in 1854.
    Benazzi F, Akiskal HS.
    J Affect Disord; 2006 Dec; 96(3):183-7. PubMed ID: 16427131
    [Abstract] [Full Text] [Related]

  • 10. Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP).
    Hantouche EG, Akiskal HS, Lancrenon S, Allilaire JF, Sechter D, Azorin JM, Bourgeois M, Fraud JP, Châtenet-Duchêne L.
    J Affect Disord; 1998 Sep; 50(2-3):163-73. PubMed ID: 9858076
    [Abstract] [Full Text] [Related]

  • 11. [Bipolar obsessive-compulsive disorder: confirmation of results of the "ABC-OCD" survey in 2 populations of patient members versus non-members of an association].
    Hantouche EG, Kochman F, Demonfaucon C, Barrot I, Millet B, Lancrenon S, Akiskal HS.
    Encephale; 2002 Sep; 28(1):21-8. PubMed ID: 11963340
    [Abstract] [Full Text] [Related]

  • 12. The duration of hypomania in bipolar-II disorder in private practice: methodology and validation.
    Benazzi F, Akiskal H.
    J Affect Disord; 2006 Dec; 96(3):189-96. PubMed ID: 16427136
    [Abstract] [Full Text] [Related]

  • 13. Atypical depression: a variant of bipolar II or a bridge between unipolar and bipolar II?
    Akiskal HS, Benazzi F.
    J Affect Disord; 2005 Feb; 84(2-3):209-17. PubMed ID: 15708418
    [Abstract] [Full Text] [Related]

  • 14. Searching for behavioral indicators of bipolar II in patients presenting with major depressive episodes: the "red sign," the "rule of three" and other biographic signs of temperamental extravagance, activation and hypomania.
    Akiskal HS.
    J Affect Disord; 2005 Feb; 84(2-3):279-90. PubMed ID: 15708427
    [Abstract] [Full Text] [Related]

  • 15. Family history validation of a definition of mixed depression.
    Benazzi F.
    Compr Psychiatry; 2005 Feb; 46(3):159-66. PubMed ID: 16021584
    [Abstract] [Full Text] [Related]

  • 16. Classifying mood disorders by age-at-onset instead of polarity.
    Benazzi F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb 01; 33(1):86-93. PubMed ID: 18992784
    [Abstract] [Full Text] [Related]

  • 17. Bipolar II vs. unipolar depression: psychopathologic differentiation by dimensional measures.
    Hantouche EG, Akiskal HS.
    J Affect Disord; 2005 Feb 01; 84(2-3):127-32. PubMed ID: 15708409
    [Abstract] [Full Text] [Related]

  • 18. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?
    Akiskal HS, Benazzi F.
    J Affect Disord; 2006 Aug 01; 94(1-3):105-10. PubMed ID: 16766043
    [Abstract] [Full Text] [Related]

  • 19. Mixed depression: a clinical marker of bipolar-II disorder.
    Benazzi F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb 01; 29(2):267-74. PubMed ID: 15694234
    [Abstract] [Full Text] [Related]

  • 20. Melancholic outpatient depression in Bipolar-II vs. unipolar.
    Benazzi F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May 01; 28(3):481-5. PubMed ID: 15093955
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 39.